{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-06-01",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "third_party_flag": "N",
      "city": "Irvine",
      "advisory_committee_description": "Ophthalmic",
      "address_1": "2525 Dupont Dr.",
      "address_2": "",
      "statement_or_summary": "Summary",
      "product_code": "QBR",
      "openfda": {
        "device_name": "Intranasal Electrostimulation Device For Dry Eye Symptoms",
        "medical_specialty_description": "Ophthalmic",
        "regulation_number": "886.5310",
        "device_class": "2"
      },
      "zip_code": "92612",
      "applicant": "Allergan",
      "decision_date": "2020-08-31",
      "decision_code": "SESE",
      "country_code": "US",
      "device_name": "TrueTear Intranasal Tear Neurostimulator",
      "advisory_committee": "OP",
      "contact": "Barbara  Simon",
      "expedited_review_flag": "",
      "k_number": "K193589",
      "state": "CA",
      "date_received": "2019-12-23",
      "review_advisory_committee": "OP",
      "postal_code": "92612",
      "decision_description": "Substantially Equivalent",
      "clearance_type": "Traditional"
    }
  ]
}